Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens

• Status: Recruiting
• Trial end date: 2025-07-01

Summary

Diabetic retinopathy (DR) is an important cause of blindness.

• Phase: Early Phase 1

Details

• Lead Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
• Treatments: Acarbose; Gliclazide; Insulin; Insulin Aspart; Insulin aspart, insulin aspart protamine drug combination 30:70; Insulin Glargine; Insulin, Globin Zinc; Metformin